Insider Trading History of Greenstein Leonard M.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Greenstein Leonard M. since 2013. This trader's CIK number is 1519692. At the time of last reporting, Greenstein Leonard M. was the Chief Financial Officer of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS). Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..

Note that in the past Greenstein Leonard M. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Endologix Inc /de/ (ELGX) by Greenstein Leonard M.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ELGX 0 $0 1,253 $17,554 0 $0

Yearly summary of insider trading at Tarsus Pharmaceuticals, Inc. (TARS) by Greenstein Leonard M.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 TARS 0 $0 21,966 $310,876 4,462 $0
2022 TARS 0 $0 10,000 $164,000 0 $0


Insider trading activities at 2 companies by Greenstein Leonard M.:

1. Endologix Inc /de/ (ELGX)

2. Tarsus Pharmaceuticals, Inc. (TARS)

Table 1. Insider trading of Endologix Inc /de/ (ELGX) by Greenstein Leonard M.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-05-28 ELGX Sale 1,253 14.01 17,554

Table 2. Insider trading of Tarsus Pharmaceuticals, Inc. (TARS) by Greenstein Leonard M.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-04-20 TARS Sale 5,000 14.02 70,100
2023-03-21 TARS Sale 326 12.89 4,202
2023-03-22 TARS Sale 332 12.64 4,196
2023-03-23 TARS Sale 346 12.15 4,203
2023-03-17 TARS Sale 316 13.28 4,196
2023-03-20 TARS Sale 333 12.61 4,199
2023-03-16 TARS Sale 5,313 13.44 71,380
2023-03-15 TARS Option Ex 4,462 .00 0
2023-02-16 TARS Sale 5,000 15.12 75,600
2023-01-19 TARS Sale 5,000 14.56 72,800
2022-11-17 TARS Sale 5,000 16.54 82,700
2022-10-20 TARS Sale 5,000 16.26 81,300

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenstein Leonard M. (Chief Financial Officer of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.